US Stock MarketDetailed Quotes
ADGM Adagio Medical
- 2.875
- +0.125+4.55%
Close Oct 16 16:00 ET
38.49MMarket Cap-964P/E (TTM)
2.900High2.585Low6.97KVolume2.590Open2.750Pre Close19.22KTurnover0.15%Turnover RatioLossP/E (Static)13.39MShares11.57052wk High0.55P/B13.27MFloat Cap2.40052wk Low--Dividend TTM4.61MShs Float12.380Historical High--Div YieldTTM11.46%Amplitude2.400Historical Low2.755Avg Price1Lot Size
About Adagio Medical Company
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development and placing on the EU market of innovative ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in New York, NY.
Company Profile
SymbolADGM
Company NameAdagio Medical
Listing DateFeb 26, 2021
Founded2020
CEOMr. Olav B. Bergheim
MarketNASDAQ
Fiscal Year Ends12-31
Address51 Astor Place,10th Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10003
Phone1-212-284-2300
Company Executives
- Name
- Position
- Salary
- Olav B. Bergheim
- Chief Executive Officer and Chairman of the Board
- --
- John T. Dahldorf
- Chief Financial Officer
- --
- Hakon Bergheim
- Chief Operating Officer
- --
- Shahram Moaddeb
- Independent Director
- --
- Dr. Keyvan Mirsaeedi-Farahani, M.D.
- Independent Director
- --
- Dr. James L. Cox, M.D.
- Independent Director
- --
- Sandra A. Gardiner
- Independent Director
- --
- Orly Mishan
- Independent Director
- --
- Timothy P. Moran
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data